Osteoporosis drug may benefit heart health
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack and stroke...
List view / Grid view
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack and stroke...
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.
Researchers synthesized self-assembling peptide amphile nanofibers that targeted areas of plaque and could be delivered by intravenous injection...
Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones...
Technique measuring the cccDNA marker may allow earlier detection of hepatocellular carcinoma in patients...
A new study found that infections caused by the drug resistant bacteria - methicillin-resistant Staphylococcus aureus, known as MRSA - are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.
Engineers have developed a microfluidic system where more than ten thousand of these devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket...
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
NIH researchers combine two microscope technologies to create sharper, faster images...
The U.S. Food and Drug Administration has approved Tafinlar and Mekinist administered together, for the treatment of anaplastic thyroid cancer that cannot be removed by surgery...
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment olaparib and other PARP inhibitors...
A new drug could ease the distress of men and women who suffer from baldness...
Reading Scientific Services Ltd (RSSL) has appointed Katarzyna Szymaniec to lead its accredited pharmaceutical training business and align its strategic development with the diverse needs of professionals working within the sector...